Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Kedudukan dalam Saham #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Harga Saham
$0.117
Disegerakkan terakhir: 2025-04-04
Modal Pasaran
$2.45M
Perubahan (1 hari)
-13.59%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Carmell Therapeutics Corporation (CTCX)

Kategori

Sejarah hasil dividen untuk Carmell Therapeutics Corporation (CTCX)
Hasil dividen (TTM) bagi Carmell Therapeutics Corporation (simbol saham: CTCX) pada 2023-12-31 adalah: 0.00%
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Carmell Therapeutics Corporation (CTCX) dari 2021 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
Hasil dividen (TTM) untuk syarikat serupa atau pesaing